Tyrosine kinase of insulin-like growth factor receptor as target for novel treatment and prevention strategies of colorectal cancer

Antzeko izenburuak

• Signaling pathways involved in the inhibition of epidermal growth factor receptor by erlotinib in hepatocellular cancer
  nork: Huether, Alexander, et al.
  Argitaratua: (2006)
• Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells
  nork: Baradari, Viola, et al.
  Argitaratua: (2007)
• A novel approach in the treatment of neuroendocrine gastrointestinal tumors: Additive antiproliferative effects of interferon-γ and meta-iodobenzylguanidine
  nork: Höpfner, Michael, et al.
  Argitaratua: (2004)
• Physical activity, insulin‐like growth factor 1, insulin‐like growth factor binding protein 3, and survival from colorectal cancer
  nork: Haydon, A M M, et al.
  Argitaratua: (2006)
• Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden
  nork: Palmqvist, R, et al.
  Argitaratua: (2002)